Cart
sales@molnova.com
Boc-Ile-Glu-Gly-Arg-AMC
CAS No. 65147-06-0
Boc-Ile-Glu-Gly-Arg-AMC( IEGR-AMC )
Catalog No. M29828 CAS No. 65147-06-0
Boc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC), a specific, highly fluorogenic substrate for clotting enzyme factor Xa (coagulation factor Xa). Boc-IEGR-AMC is also hydrolyzed by acrosin from the ascidian Halocynthia roretzi.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameBoc-Ile-Glu-Gly-Arg-AMC
-
NoteResearch use only, not for human use.
-
Brief DescriptionBoc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC), a specific, highly fluorogenic substrate for clotting enzyme factor Xa (coagulation factor Xa). Boc-IEGR-AMC is also hydrolyzed by acrosin from the ascidian Halocynthia roretzi.
-
DescriptionBoc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC), a specific, highly fluorogenic substrate for clotting enzyme factor Xa (coagulation factor Xa). Boc-IEGR-AMC is also hydrolyzed by acrosin from the ascidian Halocynthia roretzi.
-
In Vitro——
-
In Vivo——
-
SynonymsIEGR-AMC
-
PathwayMetabolic Enzyme/Protease
-
TargetFactor Xa
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65147-06-0
-
Formula Weight730.81
-
Molecular FormulaC34H50N8O10
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Boc-Ile-Glu-Gly-Arg-AMC
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Eich S, et al. Factor VIII determination in patient's plasma and concentrates: a novel test equally suited for both matrices. Blood Coagul Fibrinolysis. 2003 Jun;14(4):347-53.
molnova catalog
related products
-
Asundexian
Asundexian (BAY-2433334) is a potent and orally active inhibitor of the coagulation factor FXIa that directly and reversibly binds to the active site of FXIa, thereby inhibiting its activity.Asundexian has an IC50 of 1 nM for human FXIa in buffer.
-
Edoxaban tosylate
A potent and orally active Factor Xa inhibitor with Ki of 0.561 nM.
-
EMD-503982
EMD-503982 is a potential Factor Xa and Factor VIIa inhibitor with potential anticancer and antitumor activity for the study of thromboembolic and neurological disorders.
